CD274 and neoplasm: In a preclinical model of ATC, combination therapy involving PD-L1 blockade and NK cell-based immunotherapy significantly augmented the cytolytic efficacy of NK cells against tumor spheroids and resulted in a marked decrease in tumor load in vivo [47].